» Authors » Joachim Richter

Joachim Richter

Explore the profile of Joachim Richter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 1384
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Richter J, Kayuni S, Stothard J, Ramarokoto C, Lindner A, Fusco D, et al.
Parasitology . 2025 Feb; :1-29. PMID: 39991843
No abstract available.
2.
Paggi R, Paggi R, Lanari A, Lanari A, Malcontenti C, Malcontenti C, et al.
Travel Med Infect Dis . 2025 Feb; 64:102810. PMID: 39922332
No abstract available.
3.
Helling-Giese G, Demarta-Gatsi C, Richter J
Eur J Obstet Gynecol Reprod Biol . 2024 Oct; 303:28-34. PMID: 39396434
Introduction: Female genital schistosomiasis (FGS) is the manifestation of schistosomiasis in the lower and the upper reproductive organs. In endemic areas FGS is frequent with a tremendous impact on reproductive...
4.
Ziemssen T, Posevitz-Fejfar A, Chudecka A, Cepek L, Reifschneider G, Grothe C, et al.
Mult Scler Relat Disord . 2024 Aug; 90():105812. PMID: 39151238
Background: Cladribine tablets for the treatment of relapsing multiple sclerosis (RMS) are administered in two pulsed treatment courses in two consecutive years, totalling a maximum of 20 treatment days. Here...
5.
Martinez G, Richter J, Hammer J, Castillo M, Lavis M, Lindner A
J Travel Med . 2024 Jul; 31(7). PMID: 39030689
No abstract available.
6.
Lindner A, Castillo M, Wintel M, Martinez G, Richter J, Kurth F, et al.
PLoS Negl Trop Dis . 2024 Jul; 18(7):e0012323. PMID: 39008517
Background: American Cutaneous Leishmaniasis (ACL) shows variable response to therapy, but data on species-specific treatment efficacy is scarce. We describe the clinical characteristics and outcome of patients with ACL imported...
7.
Gerstenberg J, Mishra S, Holtfreter M, Richter J, Davi S, Okwu D, et al.
Pathogens . 2024 Jun; 13(6). PMID: 38921768
Background: Schistosome egg deposition in pregnant women may affect the placenta of infected mothers and cause placental schistosomiasis (PS). Histopathological examination of placental tissue is an inadequate detection method due...
8.
Schwab M, Chan A, Eser A, Kallmann B, Pohlau D, Richter J, et al.
Neurol Ther . 2024 Mar; 13(3):641-653. PMID: 38530606
Introduction: Treatment adherence is a critical success factor in the disease-modifying therapy (DMT) of multiple sclerosis (MS). The REBISTART study prospectively evaluated adherence in patients using components of a patient...
9.
Bottieau E, Mbow M, Brosius I, Roucher C, Gueye C, Mbodj O, et al.
Nat Med . 2024 Jan; 30(1):130-137. PMID: 38177851
Schistosomiasis treatment entirely relies on a single drug, praziquantel, prompting research into alternative therapeutics. Here we evaluated the efficacy and safety of the antimalarial combination artesunate-mefloquine for the treatment of...
10.
Pach S, Webb E, Edielu A, Nagawa R, Anguajibi V, Mpooya S, et al.
Pediatr Infect Dis J . 2023 Nov; 43(1):14-20. PMID: 37922490
Background: Periportal fibrosis is a late-stage manifestation of chronic infection with Schistosoma mansoni . Praziquantel (PZQ), the only drug available for the treatment of schistosomiasis, has limited effect in treating...